MSMilan 2023 Conference Review

In this review:
  -  NGDs which mimic MS
  -  Junior resident accuracy in recognising MS
  -  Alternative diagnoses in suspected MS
  -  Tapering of oral prednisone after intravenous methylprednisolone: optic neuritis outcomes
  -  Tolebrutinib in relapsing MS
  -  Diroximel fumarate in relapsing-remitting MS & lymphopaenia
  -  Cladribine tablets for ≥4 years in relapsing-remitting MS
  -  Subcutaneous vs. IV administration of 6-weekly natalizumab
  -  MS treatments in the elderly
  -  Thalamic volume loss & new lesion formation with ublituximab
  -  Physician visit rates prior to MS onset

Please login below to download this issue (PDF)